Tatva Chintan Pharma Chem Limited reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported sales was INR 900.91 million compared to INR 1,236.15 million a year ago. Revenue was INR 916.4 million compared to INR 1,268.6 million a year ago. Net income was INR 71.12 million compared to INR 324.12 million a year ago. Basic earnings per share from continuing operations was INR 3.21 compared to INR 15.02 a year ago. Diluted earnings per share from continuing operations was INR 3.21 compared to INR 15.02 a year ago.
For the six months, sales was INR 1,784.93 million compared to INR 2,304.47 million a year ago. Revenue was INR 1,818.71 million compared to INR 2,350.16 million a year ago. Net income was INR 169.08 million compared to INR 555.58 million a year ago. Basic earnings per share from continuing operations was INR 7.63 compared to INR 26.66 a year ago. Diluted earnings per share from continuing operations was INR 7.63 compared to INR 26.66 a year ago.